Show simple item record

dc.date.accessioned2018-01-30T16:11:53Z
dc.date.available2018-01-30T16:11:53Z
dc.date.issued2017-12-11
dc.identifier.urihttp://hdl.handle.net/10713/7437
dc.descriptionDescription of a promising cholera vaccine resulting from a study conducted in Mali by the University of Maryland, Baltimore, School of Medicine's Center for Vaccine Development (CVD). The new single-dose, live-attenuated oral vaccine is licensed and manufactured by PaxVax under the name of Vaxchora.en_US
dc.language.isoen_USen_US
dc.subjectUniversity of Maryland, Baltimore. Center for Vaccine Development (CVD)en_US
dc.subject.lcshUniversity of Maryland, Baltimore. School of Medicineen_US
dc.subject.meshCholera Vaccinesen_US
dc.titleHigh-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaksen_US
dc.typeArticleen_US
dc.description.urinameFull Texten_US
refterms.dateFOA2019-02-19T18:35:38Z


Files in this item

Thumbnail
Name:
HighDoseCholera2017.pdf
Size:
1.471Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record